Financial Assistance

Sickle cell disease (SCD) is a lifelong condition, and the real challenge is finding a clinic that can manage complications safely and consistently. In China,…

Gene-editing therapy to now be available to patients at low or no costCasgevy (exagamglogene autotemcel) will be reimbursed by Germany’s public health system,…

BOSTON--(BUSINESS WIRE)--May 6, 2026-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) announced today that a reimbursement agreement was signed with the GKV-…

What you need to know:According to the Ministry of Health, an estimated 14,000 children are born with sickle cell disease annually in Kenya, making it a significant…

The fight against sickle cell disease (SCD) has taken a significant step forward with the unveiling of a new strategic plan by the Michigan Department of Health and…

Sickle Cell Disease Regional Care Excellence Program (SoRCE) is to improve the health of people with sickle cell disease (SCD) by expanding access to care,…

WASHINGTON – Congressman Steve Cohen (TN-9) today announced that Dr. Shannon L. McKinney-Freeman of the Hematology Department at St. Jude Children’s Research…

Sickle cell disease (SCD) is one of the most common inherited blood disorders in the United States, disproportionately affecting Black Americans. And yet, despite…

Sickle cell disease (SCD) is often described as a rare condition. But for many of us, that word feels misleading. Growing up in London, a city with one of the…

Building on our long‑standing commitment to the sickle cell disease (SCD) community, Pfizer is advancing the Sickle Cell Advocacy & Leadership Empowerment (…